Central serous chorioretinopathy (CSC) is a retinal disorder that primarily affects young (20-
to 50-year-old) white men, although it is seen occasionally in older patients and females …

Central serous chorioretinopathy (CSCR) is a common retinal cause of visual loss. The
mainstays of management are observation, photodynamic therapy (PDT) and laser …

Purpose: To evaluate the safety and effects of oral eplerenone in chronic central serous
chorioretinopathy. Methods: Prospective, randomized, double-blind, placebo-control study at …

Purpose: To assess the treatment response to mineralocorticoid antagonists in a pilot study
of patients diagnosed with central serous chorioretinopathy using multimodal imaging …

AIM To examine eplerenone (Inspra, Pfizer), a mineralocorticoid receptor antagonist, as a
treatment option for chronic central serous chorioretinopathy (CSCR). METHODS A …

Purpose To evaluate the effect and tolerance of oral mineralocorticoid antagonists,
eplerenone and/or spironolactone, in recalcitrant central serous chorioretinopathy. Methods …

Central serous chorioretinopathy (CSCR) is characterised by acute or chronic neurosensory
detachments of the retina, usually in the posterior pole, with or without associated …

Central serous chorioretinopathy is a disease that is partly understood. Novel advancements
have led to further understanding of the disease, and have identified choroidal dysfunction …

Purpose To evaluate the efficacy and safety of melatonin for the treatment of chronic central
serous chorioretinopathy (CSCR). Methods Prospective comparative case series. A total of …

Purpose The purpose of this review is to examine the role of eplerenone in the treatment of
central serous chorioretinopathy (CSCR). Methods A comprehensive search of the PubMed …